Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity
about
Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 DiabetesNew Immunosuppressive Therapies in Uveitis TreatmentManipulating regulatory T cells: a promising strategy to treat autoimmunityProtective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.Immunity and immune modulation in Trypanosoma cruzi infection.Low-Dose IL-2 in the Treatment of Lupus.Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity.Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune ActivationIs There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment.Effects of exosome on the activation of CD4+ T cells in rhesus macaques: a potential application for HIV latency reactivation.Immune Tolerance Effect in Mesenteric Lymph Node Lymphocytes of Geniposide on Adjuvant Arthritis Rats.Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.Simulation of Stimulation: Cytokine Dosage and Cell Cycle Crosstalk Driving Timing-Dependent T Cell Differentiation
P2860
Q26770386-DDE69743-7842-42B5-9728-69F037AB5740Q26798201-AE6B1EF9-B161-4315-8B1B-DB5C2FCE9FC5Q28083298-694FAAB7-4294-4DDD-9109-54029B62ED84Q35501874-D1BF6271-7B5E-4DB4-94E7-1B535895E174Q38424224-86B42C36-CB88-454A-B0C1-359E6F7D6C5CQ38599837-585AF388-5BE8-431A-8BAF-9815E4BED2F1Q38979253-21284768-58F4-443E-BDE4-D2BD0AB5E310Q39163678-EC2700CC-99C8-468F-A09E-2559FAA552EAQ40625213-FE0ED833-82ED-4AED-9072-398BB1630A24Q41205365-037B2EBB-3C57-4491-9A36-F4727E9A817EQ41544597-14A91566-73A2-486C-98F8-34AFA96012A9Q45908717-0BBFB465-DD1F-4B31-B783-27E655045CE6Q48252430-9CBB5CEF-1087-4774-95E9-C6ED94862A73Q51095965-5272AA7C-99D5-4789-A58E-579180F17AA2Q58803374-E4BB49DD-B551-4AAB-B8C1-44EB34F76E2E
P2860
Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@ast
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@en
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@nl
type
label
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@ast
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@en
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@nl
prefLabel
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@ast
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@en
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@nl
P2860
P921
P3181
P356
P1476
Low-dose interleukin-2 therapy ...... une tolerance and autoimmunity
@en
P2093
Agata Kosmaczewska
P2860
P304
P3181
P356
10.3390/IJMS151018574
P407
P5008
P577
2014-10-15T00:00:00Z